Kimia Therapeutics
- Website
- kimiatx.com
- Total Funding
- $55.0M
- Last Round
- $55.0M Series ADec 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Kimia Therapeutics is a Biotech company. It has raised $55.0M in total across 1 round, most recently a $55.0M Series A round in Dec 2023. Investors include The Column Group, Dimension Capital and Horizons Ventures.
Funding History
Dec 2023
Investors
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kimia-therapeutics"><img src="https://indexed.vc/api/badge/company/kimia-therapeutics" alt="Kimia Therapeutics on Indexed.vc" width="260" height="76" /></a>